El Salvador has made history as one of the latest countries to eliminate trachoma as a public health problem, the World Health Organization (WHO) announced this week — a milestone that reflects decades of determined effort to defeat a disease that has robbed millions of their sight.
A Disease Without Mercy
Trachoma, caused by repeated infections with the bacterium Chlamydia trachomatis, is the world's leading cause of infectious blindness. It spreads easily through contaminated fingers, shared towels, and flies that carry the bacteria from one person's eyes to another. Left untreated, it causes the eyelashes to turn inward and scratch the cornea with every blink — a slow, painful, and entirely preventable path to permanent blindness.
The disease has historically been concentrated in rural, low-income communities where access to clean water and healthcare remains limited. For generations, it was one of the most stubborn obstacles standing between vulnerable communities and long-term health.
A Remarkable Turnaround
El Salvador's achievement follows years of concerted national action, guided by the WHO's SAFE strategy: Surgery for advanced cases, Antibiotic treatment to clear active infections, Facial cleanliness education, and Environmental improvements to water and sanitation infrastructure.
"El Salvador's success is a testament to strong political commitment, strategic investment, and community engagement," said WHO Director-General Dr. Tedros Adhanom Ghebreyesus. "It is a vital step towards our global target of eliminating trachoma worldwide by 2030 and a clear signal that a healthier, more equitable future is within reach."
The numbers behind the achievement are striking. Global trachoma programs have delivered more than 1.5 billion antibiotic treatments and supported hundreds of thousands of corrective surgeries over the past two decades. The cumulative result: a 94 percent decrease in the number of people at risk of trachoma since 2002. What once threatened more than a billion people worldwide has been dramatically reduced — largely through community-based action and political will.
How Elimination Is Achieved
Trachoma elimination is a multi-pronged process. Antibiotic distribution — typically a single dose of azithromycin — can clear active infection across entire communities when delivered at scale. Combined with improved sanitation and hygiene education, this approach breaks the cycle of re-infection. Surgical programs correct the dangerous inturned eyelashes of those already affected, preventing further corneal damage.
El Salvador's success required coordinating all four arms of the SAFE strategy simultaneously across its healthcare system — no small feat for any country. Community health workers played a particularly critical role, reaching households and schools in areas where formal healthcare infrastructure is limited.
Central America's Growing Health Record
El Salvador joins a growing list of nations that have earned WHO certification for trachoma elimination, including Mexico, Morocco, Oman, Iran, Cambodia, and several Pacific island nations. Each certification strengthens the global case that the disease's complete eradication by 2030 is not merely aspirational — it is achievable.
WHO notes that elimination does not mean the pathogen is entirely gone. It means the disease has been reduced to a level where it no longer constitutes a public health problem. Continued surveillance and healthcare investment are needed to prevent resurgence, particularly as climate and migration patterns evolve.
The Road to 2030
Trachoma remains endemic in parts of sub-Saharan Africa, South Asia, and the Pacific Islands. The work is not finished. But each country that crosses the elimination threshold narrows the field and builds the institutional knowledge needed to defeat the disease globally.
"No one should go blind from a disease this preventable," said Dr. Tedros. "Every elimination is proof that when communities and governments act together, they can end diseases that have haunted human history for centuries."
El Salvador's success story is a reminder that global health victories are possible — not through a single dramatic breakthrough, but through sustained commitment, community trust, and the quiet, persistent work of public health systems doing what they were built to do.
